PAR2 promotes malignancy in lung adenocarcinoma
- 1 January 2024
- journal article
- research article
- Published by e-Century Publishing Corporation in American Journal of Translational Research
- Vol. 16 (12) , 7416-7426
Abstract
Proteinase-activated receptor-2 (PAR2) is closely linked to tumor malignancy, but its biological role in cancer remains underexplored. In this study, we assessed PAR2 expression in lung adenocarcinoma (LUAD) and normal lung tissues, analyzed associations between clinicopathological features and survival rates, and confirmed that PAR2 promotes apoptosis resistance and reduces cisplatin-induced cytotoxicity in lung cancer cells. Using TCGA datasets, western blotting, qPCR, and immunohistochemistry (IHC), we observed a significant increase in PAR2 levels in LUAD samples compared to normal tissues (P<0.05), with high PAR2 expression correlating with poor differentiation and lymphatic invasion (P<0.05). Upregulated PAR2 was associated with reduced survival. Additionally, PAR2 inhibition increased the BAX/BCL-2 axis and contributed to cisplatin-induced endoplasmic reticulum stress and apoptosis in H1299 cells. However, PAR2 inhibition reduced cisplatin-induced ATF4 expression. Overall, PAR2 upregulation is strongly associated with poor postoperative survival, differentiation, and lymphatic metastasis in LUAD and modulates cisplatin cytotoxicity.Keywords
This publication has 27 references indexed in Scilit:
- Non‐small cell lung cancer in ChinaCancer Communications, 2022
- PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathwayTissue and Cell, 2022
- PAR2 blockade reverses osimertinib resistance in non-small-cell lung cancer cells via attenuating ERK-mediated EMT and PD-L1 expressionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022
- RAP2A promotes apoptosis resistance of hepatocellular carcinoma cells via the mTOR pathwayClinical and Experimental Medicine, 2021
- Lung Cancer in Republic of ChinaJournal of Thoracic Oncology, 2021
- Protease-activated receptor 2 induces migration and promotes Slug-mediated epithelial-mesenchymal transition in lung adenocarcinoma cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2019
- Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cellsMolecular Carcinogenesis, 2013
- Structure, function and pathophysiology of protease activated receptorsPharmacology & Therapeutics, 2011
- Protease-activated receptors as drug targets in inflammation and painPharmacology & Therapeutics, 2009
- Amplification of MMP‐2 and MMP‐9 production by prostate cancer cell lines via activation of protease‐activated receptorsThe Prostate, 2004